We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
125 hedge funds and large institutions have $298M invested in Atara Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
6,212% more call options, than puts
Call options by funds: $4.86M | Put options by funds: $77K
24% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 42
0.18% more ownership
Funds ownership: 4.1% → 4.28% (+0.18%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $316M → $298M (-$18.6M)
10% less funds holding
Funds holding: 139 → 125 (-14)
64% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 22
Holders
125
Holders Change
-14
Holders Change %
-10.07%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
52
Reduced
42
Closed
22
Calls
$4.86M
Puts
$77K
Net Calls
+$4.78M
Net Calls Change
-$324K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$4.94M |
| 2 |
BG
Baupost Group
Boston,
Massachusetts
|
+$3.88M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.31M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.25M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.71M |
